insights_auto
Outlook: 22.2% bullish·16.7% bearish
Go to analysischevron_right
A1RG34:BVMF
Argenx Se Bdr
၁၆၅.၄၄ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၉, GMT-၃ ၁၆:၅၆:၀၀ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for A1RG34...
Open
၁၆၅.၄၄ R$
High
၁၆၅.၄၄ R$
Low
၁၆၅.၄၄ R$
Mkt. cap
ဋေ ၅.၀၁ ထ
Avg. vol.
၅၉.၀၀
Volume
၈.၀၀
52-wk high
၂၁၃.၁၅ R$
52-wk low
၁၄၃.၂၂ R$
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
Open
၁၆၅.၄၄ R$
High
၁၆၅.၄၄ R$
Low
၁၆၅.၄၄ R$
Mkt. cap
ဋေ ၅.၀၁ ထ
Avg. vol.
၅၉.၀၀
Volume
၈.၀၀
52-wk high
၂၁၃.၁၅ R$
52-wk low
၁၄၃.၂၂ R$
Shares outstanding
၆.၂၉ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Simply Wall Street
·
ပြီးခဲ့သည့် ၁ ရက်
Could A Halted Sjögren Trial Alter The Investment Case For argenx Stock?
Yahoo Finance
·
ပြီးခဲ့သည့် ၁ ရက်
argenx (ENXTBR:ARGX) Stock May Be Fully Priced After Its 185% Run
AD HOC NEWS
·
ပြီးခဲ့သည့် ၁ ရက်
Argenx stock sits at EUR 736.30 after a week of mixed trial news
Investing.com
·
ပြီးခဲ့သည့် ၂ ရက်
H.C. Wainwright reiterates argenx stock buy rating on celiac drug data
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About Argenx Se Bdr